Product Information
BENAZEPRIL HCL 20 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0789 per EA under NDC 62135072190. Its NADAC has been published 153 times since Nov 1, 2023.
FDA first approved this application on Feb 11, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Chartwell RX LLCNDC
62135072190
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076267FDA Approved
2/11/2004
TE Code
AB
On Market Since
8/20/2022
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL HCL 20 MG TABLET has been published 153 times since Nov 1, 2023, and over the history we have for it it has risen 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0789 per EA |
|---|---|
| All-time high | $0.0809 (Dec 13, 2023) |
| All-time low | $0.0505 (Jul 17, 2024) |
| 52-week high | $0.0789 |
| 52-week low | $0.0746 |
| Median price | $0.0743 |
| Average price | $0.0713 |
| Largest weekly change | +46.5% (Aug 21, 2024) |
| Weeks tracked | 153 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Benazepril hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benazepril hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENAZEPRIL HCL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL HCL 20 MG TABLET, manufactured by Chartwell RX LLC, is $0.0789 per EA (NDC 62135072190), effective Sep 30, 2026.
How has the price of BENAZEPRIL HCL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL HCL 20 MG TABLET has risen 5.6%. It has been tracked across 153 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL HCL 20 MG TABLET?
Since Nov 1, 2023, the NADAC for BENAZEPRIL HCL 20 MG TABLET has ranged from a low of $0.0505 (Jul 17, 2024) to a high of $0.0809 (Dec 13, 2023), with a median of $0.0743 per EA.
Are there cheaper alternatives to BENAZEPRIL HCL 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BENAZEPRIL HCL 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BENAZEPRIL HCL 20 MG TABLET?
BENAZEPRIL HCL 20 MG TABLET (NDC 62135072190) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.